Predictive Human Toxicity and ADME/Tox Studies 2011
January 27 - 28, 2011
Bruxelles , Belgio
he desire to bring new drugs to market faster is a key driver of pharmaceutical companies. Being able to identify drug candidates faster with fewer missed hits has streamlined the screening process, but having insufficient knowledge of potential human toxicity early on can turn a successful drug into a devastating loss.
Mondial Research has joined with strategic partners from the Biotech and Pharmaceutical Industry to bring together scientific experts to present and discuss recent advances towards accurately predicting human toxicities and screening earlier in the drug discovery process. This event will also cover topics on toxicogenomics, in-silico tools, ADME/Tox and pharmacokinetics. Our goal is to provide a platform for forging a better understanding of the issues at hand in order that regulatory agencies may develop better policies and to assist the pharmaceutical industry in delivering safer drugs to market.
Who Should Attend:
Senior level directors, managers and scientists in drug discovery, preclinical development, ADME, DMPK, pharmokinetics, drug metabolism, toxicology, computational chemistry, molecular modeling, cheminformatics, drug design, biomolecular screening, physical chemistry, medicinal chemistry, lead optimization. Senior Executives, Heads and VP's of Applied Research, Applied Biology, Bioinformatics, Biology, Chemistry, Medical Affairs, Pre-Clinical Development, R&D, Regulatory Affairs, Scientific Affairs
Mondial Research has joined with strategic partners from the Biotech and Pharmaceutical Industry to bring together scientific experts to present and discuss recent advances towards accurately predicting human toxicities and screening earlier in the drug discovery process. This event will also cover topics on toxicogenomics, in-silico tools, ADME/Tox and pharmacokinetics. Our goal is to provide a platform for forging a better understanding of the issues at hand in order that regulatory agencies may develop better policies and to assist the pharmaceutical industry in delivering safer drugs to market.
Who Should Attend:
Senior level directors, managers and scientists in drug discovery, preclinical development, ADME, DMPK, pharmokinetics, drug metabolism, toxicology, computational chemistry, molecular modeling, cheminformatics, drug design, biomolecular screening, physical chemistry, medicinal chemistry, lead optimization. Senior Executives, Heads and VP's of Applied Research, Applied Biology, Bioinformatics, Biology, Chemistry, Medical Affairs, Pre-Clinical Development, R&D, Regulatory Affairs, Scientific Affairs
Sede
Location: Sheraton Brussels Hotel
Overview
Rising high above the Brussels skyline, the Sheraton Brussels Hotel is a four-star hotel in the heart of the city’s business district. We are a short stroll from Brussels’ main shopping area..
(32)(2) 2243111
Eventi correlati
Predictive Human Toxicity and ADME/Tox Studies January 27 - 28, 2011
